The Latest Research on CDK 4/6 Inhibitors
Three CDK 4/6 inhibitors palbociclib (Ibrance®), ribociclib (Kisqali®), and abemaciclib (Verzenio®) are FDA approved for treating people with hormone...
Read More PAST ARTICLES
2022
2021
- Metastatic Breast Cancer News from 2021 ESMO
- Metastatic Breast Cancer News from ASCO 2021
- MBC News from 2021 AACR Meeting
- St. Gallen International Breast Cancer Conference 2021
- 2021 Miami Breast Cancer Conference
- FDA Approves MARGENZA
- What is Next-Generation Sequencing?
- Lines of Therapy: New Drugs May Change MBC Treatment
2020
SEARCH OUR SITE
for past articles or specific information.